Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype

Human Pathology

Volumn 44, Issue 11, 2013, Pages 2487-2493

  Vandenbussche, Christopher J ^a   Elwood, Hillary ^a   Cimino Mathews, Ashley ^a   Bittar, Zeid ^b   Illei, Peter B ^a   Warzecha, Hind Nassar ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Ductal carcinoma in situ (DCIS); Molecular subtype; Young women

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; ANTIBODY LABELING; ARTICLE; BREAST BIOPSY; CANCER DIAGNOSIS; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MOLECULAR PATHOLOGY; PARTIAL MASTECTOMY; TRIPLE NEGATIVE BREAST CANCER; TUMOR BIOPSY;

DUCTAL CARCINOMA IN SITU (DCIS); MOLECULAR SUBTYPE; YOUNG WOMEN;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DEMOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84885582035     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.06.007     Document Type: Article

References (30)

1. C. DeSantis, R. Siegel, P. Bandi, and A. Jemal Breast cancer statistics, 2011 CA Cancer J Clin 61 2011 409 418
2. C. Tunon-de-Lara, C. Lemanski, and C. Cohen-Solal-Le-Nir Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk Eur J Surg Oncol 36 2010 1165 1171
3. K.J. Van Zee, L. Liberman, and B. Samli Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age Cancer 86 1999 1757 1767
4. S.J. Schnitt Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics J Natl Cancer Inst Monogr 2010 2010 158 161
5. N. Bijker, J.L. Peterse, and L. Duchateau Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853 J Clin Oncol 19 2001 2263 2271
6. E.R. Fisher, J. Dignam, and E. Tan-Chiu Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma Cancer 86 1999 429 438
7. L.J. Solin, A. Fourquet, and F.A. Vicini Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast Cancer 103 2005 1137 1146
8. N.S. Goldstein, F.A. Vicini, L.L. Kestin, and M. Thomas Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age Cancer 88 2000 2553 2560
9. C. Tunon-de-Lara, G. Andre, and G. Macgrogan Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients Ann Surg Oncol 18 2011 1372 1379
10. N.S. El Saghir, M. Seoud, and M.K. Khalil Effects of young age at presentation on survival in breast cancer BMC Cancer 6 2006 194
11. F.A. Vicini, L.L. Kestin, and N.S. Goldstein Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy J Clin Oncol 18 2000 296 306
12. L.C. Collins, N. Achacoso, and L. Nekhlyudov Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients Am J Surg Pathol 33 2009 1802 1808
13. K. Kerlikowske, A.M. Molinaro, and M.L. Gauthier Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis J Natl Cancer Inst 102 2010 627 637
14. N.A. Rodrigues, D. Dillon, D. Carter, N. Parisot, and B.G. Haffty Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women Cancer 97 2003 1393 1403
15. P. Meijnen, H.S. Oldenburg, J.L. Peterse, H. Bartelink, and E.J. Rutgers Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast Ann Surg Oncol 15 2008 235 243
16. H.L. Fedor, and A.M. De Marzo Practical methods for tissue microarray construction Methods Mol Med 103 2005 89 101
17. L.A. Carey, C.M. Perou, and C.A. Livasy Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2006 2492 2502
18. R.M. Tamimi, H.J. Baer, and J. Marotti Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer Breast Cancer Res 10 2008 R67
19. S.E. Clark, J. Warwick, R. Carpenter, R.L. Bowen, S.W. Duffy, and J.L. Jones Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease Br J Cancer 104 2011 120 127
20. M.E. Hammond, D.F. Hayes, and M. Dowsett American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J Clin Oncol 28 2010 2784 2795
21. A.C. Wolff, M.E. Hammond, and J.N. Schwartz American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 2007 118 145
22. T.O. Nielsen, F.D. Hsu, and K. Jensen Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 2004 5367 5374
23. M.C. Cheang, S.K. Chia, and D. Voduc Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 2009 736 750
24. E. Rakovitch, S. Nofech-Mozes, and W. Hanna HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ Br J Cancer 106 2012 1160 1165
25. R. Alvarado, S.A. Lari, and R.E. Roses Biology, treatment, and outcome in very young and older women with DCIS Ann Surg Oncol 19 2012 3777 3784
26. C.J. VandenBussche, N. Khouri, and E. Sbaity Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively Am J Surg Pathol 37 2013 913 923
27. R. Rabinovitch, L.J. Solin, and B. Shank Expert Panel on Radiation Oncology-Breast Work Group. Ductal carcinoma in situ 2006 American College of Radiology Reston, VA
28. E.S. Hwang The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy J Natl Cancer Inst Monogr 2010 2010 197 199
29. S.A. Joslyn Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival Breast J 12 2006 20 27
30. H. Nassar, B. Sharafaldeen, K. Visvanathan, and D. Visscher Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome Cancer 115 2009 3181 3188